TWM479761U - 乳酸菌包埋結構 - Google Patents
乳酸菌包埋結構 Download PDFInfo
- Publication number
- TWM479761U TWM479761U TW103203351U TW103203351U TWM479761U TW M479761 U TWM479761 U TW M479761U TW 103203351 U TW103203351 U TW 103203351U TW 103203351 U TW103203351 U TW 103203351U TW M479761 U TWM479761 U TW M479761U
- Authority
- TW
- Taiwan
- Prior art keywords
- lactic acid
- acid bacteria
- embedding structure
- structure according
- layer
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims description 106
- 239000004310 lactic acid Substances 0.000 title claims description 53
- 235000014655 lactic acid Nutrition 0.000 title claims description 53
- 241000894006 Bacteria Species 0.000 title claims description 50
- 230000002093 peripheral effect Effects 0.000 claims description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 8
- 229940069428 antacid Drugs 0.000 claims description 8
- 239000003159 antacid agent Substances 0.000 claims description 8
- 230000001458 anti-acid effect Effects 0.000 claims description 8
- 230000003064 anti-oxidating effect Effects 0.000 claims description 8
- 244000005700 microbiome Species 0.000 claims description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 6
- 239000001913 cellulose Substances 0.000 claims description 6
- 229920002678 cellulose Polymers 0.000 claims description 6
- 235000010980 cellulose Nutrition 0.000 claims description 6
- 239000000306 component Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 229920000084 Gum arabic Polymers 0.000 claims description 5
- 241000186660 Lactobacillus Species 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 235000010489 acacia gum Nutrition 0.000 claims description 5
- 239000000205 acacia gum Substances 0.000 claims description 5
- 239000000084 colloidal system Substances 0.000 claims description 5
- 229940039696 lactobacillus Drugs 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- 229920001542 oligosaccharide Polymers 0.000 claims description 5
- 150000002482 oligosaccharides Chemical class 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 4
- 241001474374 Blennius Species 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- 241000099188 Aerococcus sp. Species 0.000 claims description 3
- 229920001817 Agar Polymers 0.000 claims description 3
- 241000131482 Bifidobacterium sp. Species 0.000 claims description 3
- 241000229225 Carnobacterium sp. Species 0.000 claims description 3
- 241001495410 Enterococcus sp. Species 0.000 claims description 3
- 241000186610 Lactobacillus sp. Species 0.000 claims description 3
- 241000178948 Lactococcus sp. Species 0.000 claims description 3
- 239000005913 Maltodextrin Substances 0.000 claims description 3
- 229920002774 Maltodextrin Polymers 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 102000014171 Milk Proteins Human genes 0.000 claims description 3
- 108010011756 Milk Proteins Proteins 0.000 claims description 3
- 241000202223 Oenococcus Species 0.000 claims description 3
- 241000194022 Streptococcus sp. Species 0.000 claims description 3
- 241000018711 Vagococcus sp. Species 0.000 claims description 3
- 229920001938 Vegetable gum Polymers 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 235000010410 calcium alginate Nutrition 0.000 claims description 3
- 239000000648 calcium alginate Substances 0.000 claims description 3
- 229960002681 calcium alginate Drugs 0.000 claims description 3
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 3
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- 239000003292 glue Substances 0.000 claims description 3
- 229940035034 maltodextrin Drugs 0.000 claims description 3
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 235000010981 methylcellulose Nutrition 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 235000021239 milk protein Nutrition 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- 241001627205 Leuconostoc sp. Species 0.000 claims description 2
- 241000604136 Pediococcus sp. Species 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- 239000008358 core component Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 2
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- 241000978776 Senegalia senegal Species 0.000 claims 1
- 241000191967 Staphylococcus aureus Species 0.000 claims 1
- 239000010410 layer Substances 0.000 description 23
- 230000000694 effects Effects 0.000 description 12
- 210000001035 gastrointestinal tract Anatomy 0.000 description 9
- 239000002245 particle Substances 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 102000038379 digestive enzymes Human genes 0.000 description 5
- 108091007734 digestive enzymes Proteins 0.000 description 5
- 239000003833 bile salt Substances 0.000 description 4
- 244000215068 Acacia senegal Species 0.000 description 3
- 229940093761 bile salts Drugs 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000006041 probiotic Substances 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000001078 anti-cholinergic effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000013588 oral product Substances 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000873388 Weissella sp. Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229940023486 oral product Drugs 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
本創作係有關於微生物組成物之結構,特別係指一種乳酸菌包埋結構。
按,乳酸菌係統稱能用以代謝醣類而產生乳酸之微生物,自過去就被人類長期使用於發酵物上至今,因而更普遍地被認為係為一種十分安全之菌種。近年來之研究更證實絕大多數乳酸菌不盡廣泛地存在於人體腸道中,並且對於人體健康有正向關聯性,更與壽命長短有所關聯。舉例來說,乳酸菌對於人體具有以下優點:促進腸道內益菌多於壞菌,刺激腸道蠕動,幫助消化;強化人體免疫細胞之活性,增加免疫力;減緩過敏現象之發生,改善過敏體質;具有降低血壓、血糖及膽固醇之功效等;預防泌尿生殖系統受到細菌感染。
然而,現代人不僅因為工作壓力及外食習慣,造成腸胃道內益生菌相不易維持,並且基於抗生素之使用氾濫,更使得人體腸道內乳酸菌或其他益生菌受到破壞;換言之,腸胃道內之病原菌數量相對增加,使得人體抵抗力下降,進而影響到健康狀態。因此,目前市面上出現各類乳酸菌相關口服產品,例如發酵乳飲品、乳酸菌粉末、含有乳酸菌之錠劑等,用以提供人體服用而補充體內乳酸菌數量,惟,由於人體消化道內具有多
種消化酵素,如胃酸、膽鹽,皆具分解進入腸胃道物質之功用,是以,含有乳酸菌之口服產品進入腸胃道內後,則會被消化酵素破壞而不具有活性。亦有透過膠囊包裹乳酸菌之方式避免乳酸菌活性被消化酵素破壞,然而由於膠囊係無法完全阻隔環境濕度或溫度,因而仍會使乳酸菌無法長時間地維持其活性且被保存,更有可能會因為接觸氧氣,使乳酸菌或其代謝產物氧化而影響到對於人體之活性。
據此,目前習知技術中仍未完整提供能夠用以長時間維持乳酸菌活性,並且同時能夠抵抗人體內消化酵素作用之乳酸菌包埋結構。
因此,本創作之主要目的係在於提供一種乳酸菌包埋結構,用以避免被腸胃道中消化酵素破壞,能於腸道內釋放而發揮其促進人體健康之功效。
本創作之另一目的係在於提供一種乳酸菌包埋結構,用以抵抗外在環境之影響,如水分、溫度、壓力,而能長時間地維持乳酸菌活性。
緣是,為達成上述目的,本創作所揭一種乳酸菌包埋結構,其包含有一核心,一乳酸菌粒,包埋於該核心內;一抗氧化層,包覆於該核心外周側;一外殼,包覆於該抗氧化層外周側。
根據本創作,該外殼係具有一抗膽鹽層,包覆於該抗氧化層外周側,一抗酸層,包覆於該抗膽鹽層之外周側,其中:該抗膽鹽層之成份係得為膠質、甲基纖維素或任何用以抗膽鹽作用之成份。
該抗酸層之成份係得選為膠質、幾丁聚糖、乳蛋白或任何用
以抗胃酸作用之成份。
根據本創作,該核心之成份係得為乳糖、蔗糖、木寡醣、菊醣、半乳糖、寡醣、果寡醣、植物膠、動物膠、海藻膠、褐藻酸鈣或上述至少任二成份之組合。
根據本創作,乳酸菌粒係來自至少一乳酸菌屬之微生物,其中,該乳酸菌屬之微生物係得為乳酸桿菌(Lactobacillus
sp.)、雙歧桿菌(Bifidobacterium
sp.)、乳酸球菌(Lactococcus
sp.)、念球菌(Lcuconostoc
sp.)、小球菌(Pediococcus
sp.)、鏈球菌(Streptococcus
sp.)、需氧球菌(Aerococcus
sp.)、肉食桿菌(Carnobacterium
sp.)、腸球菌(Enterococcus
sp.)、酒球菌(Oenococcus
sp.)、俳徊球菌(Vagococcus
sp.)或魏斯氏菌(Weisella
sp.)。
根據本創作,該抗氧化層之成份係得明膠、海藻酸鈉、纖維素、奶粉、麥芽糊精、阿拉伯膠、維生素、蔗糖、乳糖、寡糖、瓊脂、乳化劑或上述至少任二成份之組合。
(10)‧‧‧乳酸菌包埋結構
(20)‧‧‧核心
(30)‧‧‧乳酸菌粒
(40)‧‧‧抗氧化層
(50)‧‧‧外殼
(51)‧‧‧抗膽鹽層
(52)‧‧‧抗酸層
第一圖係為本創作較佳實施例之剖示圖。
以下,為能更進一步說明本創作,將茲舉本創作之較佳實施例並搭配圖式做詳細說明如后。
請參閱第一圖,本創作較佳實施例所揭乳酸菌包埋結構(10)係由一核心(20)、一乳酸菌粒(30)、一抗氧化層(40)及一外殼(50)所組成者,其中:該核心(10)係設為一球形體,而得包含,但不限於,醣類、
膠質、海藻膠、褐藻酸鈣或是上述成份之組合。
該乳酸菌粒(30)係均勻地包埋於該核心(20)內,更進一步來說,該乳酸菌粒(30)係可為至少一乳酸菌屬微生物、其代謝產物、其發酵液或其發酵產物。
於本創作之實施例中,該乳酸菌屬微生物係得為乳酸桿菌(Lactobacillus
sp.)、雙歧桿菌(Bifidobacterium
sp.)、乳酸球菌(Lactococcus
sp.)、念球菌(Leuconostoc
sp.)、小球菌(Pediococcus
sp.)、鏈球菌(Streptococcus
sp.)、需氧球菌(Aerococcus
sp.)、肉食桿菌(Carnobacterium
sp.)、腸球菌(Enterococcus
sp.)、酒球菌(Oenococcus
sp.)、俳徊球菌(Vagococcus
sp.)或魏斯氏菌(Weisella
sp.)。
該抗氧化層(40)係包覆於該核心(20)外周側,包含有,但不限於,明膠、海藻酸鈉、纖維素、奶粉、麥芽糊精、阿拉伯膠、維生素、蔗糖、乳糖、寡醣、瓊脂、乳化劑等成份,用以使該核心(20)中該乳酸菌粒(30)不易接觸到空氣,減少氧化反應或潮化現象之發生,俾使該乳酸菌粒(30)能夠穩定地被保存,同時維持其活性。
該外殼(50)係具有一抗膽鹽層(51),包覆於該抗氧化層(40)外周側,一抗酸層(52),包覆於該抗膽鹽層(51)之外周側。
該抗膽鹽層(51)係由膠質或纖維素等高分子物質所組成,用以使該乳酸菌粒(30)進入人體內時能抵抗膽鹽之破壞;其中,膠質係得為動物膠、植物膠、果膠、海藻膠、阿拉伯膠、明膠、洋菜膠或上述至少二成份之混合物等,纖維素係得為甲基纖維素。
該抗酸層(52)係包含,但不限於,膠質、纖維素或乳蛋白
等成份,用以避免該乳酸菌粒(30)受到胃酸之破壞,以維持其活性至腸道釋放,俾能達到促進人體健康之功效。
藉由上述構件之組合,其係將該乳酸菌粒(30)包埋於該核心(20)中,並且透過多層保護層包覆設於該核心外(20)之結構,使該乳酸菌粒(30)能夠抵抗外在環境之不良影響,並且延緩其於人體內釋放效率,以確保人體能夠以口服方式補充到有效量且具活性之乳酸菌,維持體內穩定之益生菌菌相。
由上可知,本創作所揭乳酸菌包埋結構係能避免乳酸菌受到濕度、溫度、壓力等環境因子之影響而變質之情形,並且於長時間保存下仍能維持乳酸菌、其代謝產物或其發酵物之活性,俾以減少體內病原菌之滋生,而達到促進人體健康、提高抵抗力、抗菌等功效。
以上僅是透過本創作之較佳實施例說明本創作之申請專利範圍及說明書,並非限制本創作之目的;因此,對於本創作所揭技術特徵之簡單改變或是外型變化,皆應屬於本創作所保護之範疇。
(10)‧‧‧乳酸菌包埋結構
(20)‧‧‧核心
(30)‧‧‧乳酸菌粒
(40)‧‧‧抗氧化層
(50)‧‧‧外殼
(51)‧‧‧抗膽鹽層
(52)‧‧‧抗酸層
Claims (8)
- 一種乳酸菌包埋結構,其包含有:一核心;一乳酸菌粒,包埋於該核心內;一抗氧化層,包覆於該核心外周側;一外殼,包覆於該抗氧化層外周側。
- 依據申請專利範圍第1項所述乳酸菌包埋結構;其中,該外殼係具有一抗膽鹽層,包覆於該抗氧化層外周側,一抗酸層,包覆於該抗膽鹽層之外周側。
- 依據申請專利範圍第1項所述乳酸菌包埋結構;其中,該核心之成份係選自由乳糖、蔗糖、木寡醣、菊醣、半乳糖、寡醣、果寡醣、植物膠、動物膠、海藻膠、褐藻酸鈣及上述至少任二成份之組合所組成之群。
- 依據申請專利範圍第1項所述乳酸菌包埋結構;其中,該乳酸菌粒係來自至少一乳酸菌屬之微生物。
- 依據申請專利範圍第4項所述乳酸菌包埋結構;其中,該乳酸菌屬之微生物係選自由乳酸桿菌(Lactobacillus sp.)、雙歧桿菌(Bifidobacterium sp.)、乳酸球菌(Lactococcus sp.)、念球菌(Leuconostoc sp.)、小球菌(Pediococcus sp.)、鏈球菌(Streptococcus sp.)、需氧球菌(Aerococcus sp.)、肉食桿菌(Carnobacterium sp.)、腸球菌(Enterococcus sp.)、酒球菌(Oenococcus sp.)、俳徊球菌(Vagococcus sp.)或魏斯氏菌(Weisella sp.)所組成之群。
- 依據申請專利範圍第1項所述乳酸菌包埋結構;其中,該抗氧化層之成份係選自由明膠、海藻酸鈉、纖維素、奶粉、麥芽糊精、阿拉伯膠、維生素、蔗糖、乳糖、寡醣、瓊脂、乳化劑及上述至少任二成份之組合所組成之群。
- 依據申請專利範圍第2項所述乳酸菌包埋結構;其中,該抗膽鹽層之成份係選自由膠質及甲基纖維素所組成之群。
- 依據申請專利範圍第2項所述乳酸菌包埋結構;其中,該抗酸層之成份係選自由膠質、幾丁聚糖及乳蛋白所組成之群。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW103203351U TWM479761U (zh) | 2014-02-26 | 2014-02-26 | 乳酸菌包埋結構 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW103203351U TWM479761U (zh) | 2014-02-26 | 2014-02-26 | 乳酸菌包埋結構 |
Publications (1)
Publication Number | Publication Date |
---|---|
TWM479761U true TWM479761U (zh) | 2014-06-11 |
Family
ID=51395070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW103203351U TWM479761U (zh) | 2014-02-26 | 2014-02-26 | 乳酸菌包埋結構 |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWM479761U (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI587863B (zh) * | 2016-01-29 | 2017-06-21 | Grape King Inc | A probiotic entrapping particle |
-
2014
- 2014-02-26 TW TW103203351U patent/TWM479761U/zh not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI587863B (zh) * | 2016-01-29 | 2017-06-21 | Grape King Inc | A probiotic entrapping particle |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Huq et al. | Encapsulation of probiotic bacteria in biopolymeric system | |
Singhi et al. | Probiotics in critically ill children | |
Kailasapathy et al. | Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. | |
Ozyurt et al. | Properties of probiotics and encapsulated probiotics in food | |
Hu et al. | Dietary additive probiotics modulation of the intestinal microbiota | |
CN105595359A (zh) | 一种定位缓释微囊益生菌及其制备方法 | |
Shipradeep et al. | Development of probiotic candidate in combination with essential oils from medicinal plant and their effect on enteric pathogens: a review | |
KR20180081170A (ko) | 당을 전혀 또는 거의 함유하지 않은 안정한 건조 조성물 | |
de Souza Leone et al. | Evaluation of dried yacon (Smallanthus sonchifolius) as an efficient probiotic carrier of Lactobacillus casei LC-01 | |
TWM559176U (zh) | 以硒複合物包埋乳酸菌之抗氧化活性微膠囊結構 | |
WO2018018783A1 (zh) | 一种益生菌整理剂的制作方法 | |
TWM479761U (zh) | 乳酸菌包埋結構 | |
TWM603763U (zh) | 一種含有益生菌與益生質組合的膠囊結構 | |
TWM585623U (zh) | 口服益生菌之多層包覆晶球結構 | |
TWM487084U (zh) | 包覆乳酸菌之微膠囊結構體 | |
TWM602906U (zh) | 黃金克菲爾菌之外層微粒包埋結構 | |
CN210331170U (zh) | 一种宠物用益生菌微胶囊 | |
Sharma et al. | Pre-and probiotics: Using functional foods in the fight against microbial resistance to antibiotics | |
TWM602907U (zh) | 可運用在改善腸道微生物組的多層益生菌顆粒結構 | |
TWM646187U (zh) | 乳酸菌多層包埋結構 | |
CN206214443U (zh) | 以猴头菇菌丝包埋可提升神经生长因子乳酸菌的包埋颗粒 | |
CN204864144U (zh) | 副干酪乳杆菌微胶囊颗粒 | |
Guo et al. | Comparative evaluation of three Lactobacilli with strain-specific activities for rats when supplied in drinking water | |
Yuen | Effects of inulin, fructooligosaccharide, and breadfruit fiber on biofilm formation, growth, and gastrointestinal survival of probiotic yeast and bacteria | |
Ibrahim | The Nature and Manufacturing of Probiotics/Prebiotics for Gastrointestinal Health and Other Health Benefits |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4K | Annulment or lapse of a utility model due to non-payment of fees |